Form EFFECT Terns Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 7, 2026 |
| Accession Number: | 0001193125-26-205352 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zcash Price Prediction: ZEC Eyes $1,500 After ETF AUM Tops $500M, AlphaPepe Nears Stage 20 Sellout
- Karl-Anthony Towns, Halle Berry, Zac Posen, Danny Meyer and Sara Foster Were Among the Speakers at Today’s Fifth Annual Retail Influencer CEO Forum
- Yacht Lettering Expands Custom Yacht Lettering Focus as South Florida's Superyacht Market Advances
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
